MOVEMENT ANALYSIS IN PATIENTS UNDERGOING VERTEBRECTOMIES FOR SPINE ONCOLOGY: A PILOT STUDY

December 24, 2025 updated by: Istituto Ortopedico Rizzoli

MOVEMENT ANALYSIS IN PATIENTS UNDERGOING VERTEBRECTOMIES FOR THE TREATMENT OF SPINE ONCOLOGY: A PILOT STUDY

Analyze the geometric and kinematic parameters of the spine in patients undergoing vertebrectomy through gait analysis, both during the execution of motor tasks such as walking, standing, and basic trunk movements, with the aim of improving the assessment and, therefore, possibly, the treatment and the final clinical outcome.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

10

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Italy
      • Bologna, Italy, 40136
        • Istituto Ortopedico Rizzoli

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

patients with vertebral tumors undergoing vertebrectomy

Description

Inclusion Criteria:

  • Age 18 years or older
  • Presence of spinal cancer with surgical indication for vertebrectomy
  • Approval and signature of informed consent for the study
  • Ability to undergo movement analysis before the surgery and the 6-month follow-up

Exclusion Criteria:

  • Under 18 years of age
  • Presence of degenerative, traumatic, or infectious pathologies or spinal deformities
  • Absence of a signed informed consent form
  • Inability to undergo movement analysis before the surgery or the 6-month follow-up

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
vertebrectomy
patients with vertebral tumors undergoing vertebrectomy
Other: vertebrectomy
en bloc resection of oncological vertebra

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gait Analysis
Time Frame: 6 months after vertebrectomy
Measure and correlate geometric and kinematic parameters of the trunk and spine through instrumental motion analysis, before and after vertebrectomy surgery in patients with oncological spinal diseases.
6 months after vertebrectomy

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
questionnaire
Time Frame: 6 months after vertebrectomy
Evaluate patient-reported functional outcomes through self-administered questionnaires: Oswestry Disability Index and Fall Efficacy Scale-International
6 months after vertebrectomy
spino-pelvic parameters
Time Frame: 6 months after vertebrectomy
Measure the geometric spino-pelvic parameters (static) and compare them with the kinematic parameters (dynamic)
6 months after vertebrectomy

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Istituto Ortopedico Rizzoli

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 3, 2023

Primary Completion (Actual)

December 20, 2024

Study Completion (Actual)

December 21, 2025

Study Registration Dates

First Submitted

December 24, 2025

First Submitted That Met QC Criteria

December 24, 2025

First Posted (Actual)

January 8, 2026

Study Record Updates

Last Update Posted (Actual)

January 8, 2026

Last Update Submitted That Met QC Criteria

December 24, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • GAV

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spine Tumor

Clinical Trials on vertebrectomy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe